References
- 1. M. A. Duggan, W. F. Anderson, S. Altekruse, L. Penberthy, and M. E. Sherman, “The Surveil-lance, Epidemiology, and End Results (SEER) Program and Pathology,” Am. J. Surg. Pathol., vol. 40, no. 12, pp. e94–e102, 2016, doi: 10.1097/pas.0000000000000749.
- 2. J. Gandhi et al., “Population-based study demonstrating an increase in colorectal cancer in young patients,” Br. J. Surg., vol. 104, no. 8, pp. 1063–1068, 2017, doi: 10.1002/bjs.10518.28378448
- 3. F. G. Campos, A. Habr-Gama, S. C. Nahas, and R. O. Perez, “Abdominoperineal excision: Evolution of a centenary operation,” Dis. Colon Rectum, vol. 55, no. 8, pp. 844–853, 2012, doi: 10.1097/DCR.0b013e31825ab0f7.22810469
- 4. E. Rullier et al., “Intersphincteric resection with excision of internal anal sphincter for conservative treatment of very low rectal cancer,” Dis. Colon Rectum, vol. 42, no. 9, pp. 1168–1175, 1999, doi: 10.1007/BF02238569.10496557
- 5. R. J. Heald, R. K. Smedh, A. Kald, R. Sexton, and B. J. Moran, “Abdominoperineal excision of the rectum--an endangered operation. Norman Nigro Lectureship.,” Dis. Colon Rectum, vol. 40, no. 7, pp. 747–51, 1997, [Online]. Available: http://www.ncbi.nlm.nih.gov/pubmed/9221846.10.1007/BF020554259221846
- 6. G. Jurell and J. Lagergren, “Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer,” pp. 232–238, 2007, doi: 10.1002/bjs.5489.17143848
- 7. J. G. Han, Z. J. Wang, G. H. Wei, Z. G. Gao, Y. Yang, and B. C. Zhao, “Randomized clinical trial of conventional versus cylindrical abdominoperineal resection for locally advanced lower rectal cancer,” Am. J. Surg., vol. 204, no. 3, pp. 274–282, 2012, doi: 10.1016/j.amjsurg.2012.05.001.22920402
- 8. Sayers, A E et al. “Perineal hernia formation following extralevator abdominoperineal excision.” Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland vol. 17,4 (2015): 351-5. doi: 10.1111/codi.1284325413255
- 9. A. Huang, H. Zhao, and T. Ling, “Oncological superiority of extralevator abdominoperineal resection over conventional abdominoperineal resection : a meta-analysis,” pp. 321–327, 2014, doi: 10.1007/s00384-013-1794-6.24385025
- 10. D. Asplund, E. Haglind, and E. Angenete, “Outcome of extralevator abdominoperineal excision compared with standard surgery : results from a single centre,” pp. 1191–1196, 2012, doi: 10.1111/j.1463-1318.2012.02930.x.22221401
- 11. A. Carpelan, “Extralevator versus standard abdominoperineal excision in locally advanced rectal cancer : a retrospective study with long-term follow-up,” 2018.10.1007/s00384-018-2977-y29445870
- 12. A. N. D. Study, “ExtraLevatory AbdominoPerineal Excision (ELAPE) Does Not Result in Reduced Rate of Tumor Perforation or Rate of Positive Circumferential Resection Margin,” vol. 261, no. 5, pp. 933–938, 2015, doi: 10.1097/SLA.0000000000000910.25211268
- 13. A. Hussain, F. Mahmood, A. D. W. Torrance, H. Clarke, C. Howitt, and R. Dawson, “Oncological outcomes of abdominoperineal resection for the treatment of low rectal cancer : A retrospective review of a single UK tertiary centre experience,” Ann. Med. Surg., vol. 34, no. June, pp. 28–33, 2018, doi: 10.1016/j.amsu.2018.06.007.612580230191062
- 14. Tao, Yu et al. “Extralevator abdominoperineal excision for advanced low rectal cancer: Where to go.” World journal of gastroenterology vol. 26,22 (2020): 3012-3023. doi: 10.3748/wjg.v26. i22.3012
- 15. X. Qi et al., “Extralevator abdominoperineal excision versus abdominoperineal excision for low rectal cancer : a meta-analysis,” vol. 0, no. 20, pp. 2446–2456, 2019, doi: 10.1097/CM9.0000000000000485.683105931651517
- 16. A. Bradley, A. Hammad, and A. Mukherjee, “Extralevator abdominoperineal excision (Elape): A retrospective cohort study,” vol. 10, pp. 32–35, 2016, doi: 10.1016/j.amsu.2016.07.016.497122927508080
- 17. L. Felipe, D. C. E. Aleman, and B. B. Vailati, “Extralevator Abdominal Perineal Excision Versus Standard Abdominal Perineal Excision : Impact on Quality of the Resected Specimen and Postoperative Morbidity,” no. 2, pp. 2–9, 2017, doi: 10.1007/s00268-017-3963-1.28265736
- 18. G. Papp, K. Dede, and A. Bursics, “Short-term advantages of ELAPE over APR,” Acta Chir. Belg., vol. 121, no. 5, pp. 327–332, 2021, doi: 10.1080/00015458.2020.1778265.32496868
- 19. M. Nyandowe, A. Egedovo, and Y.-H. Ho, “A comparative study of standard versus extralevator abdominoperineal resections,” Int. Surg. J., vol. 4, no. 4, p. 1222, 2017, doi: 10.18203/2349-2902.isj20170921.
- 20. D. Kamali, A. Sharpe, A. Musbahi, and A. Reddy, “Oncological and quality of life outcomes following extralevator versus standard abdominoperineal excision for rectal cancer,” pp. 402–409, 2017, doi: 10.1308/rcsann.2017.0038.544970528462642
- 21. Z. Shen et al., “Prospective controlled study of the safety and oncological outcomes of ELAPE procure with definitive anatomic landmarks versus conventional APE for lower rectal cancer,” vol. 41, pp. 472–477, 2015, doi: 10.1016/j.ejso.2015.01.017.25659773
- 22. Colov, Emilie P et al. “Wound Complications and Perineal Pain After Extralevator Versus Standard Abdominoperineal Excision: A Nationwide Study.” Diseases of the colon and rectum vol. 59,9 (2016): 813-21. doi: 10.1097/DCR.000000000000063927505109
- 23. H. Zhang et al., “Long-term outcomes after extra-levator versus conventional abdominoperineal excision for low rectal cancer,” BMC Surg., vol. 22, no. 1, pp. 1–10, 2022, doi: 10.1186/s12893-022-01692-y.921912035733206